Abstract. K + channels are key molecules in the progression of several cancer types and considered to be potential targets for cancer therapy. We examined the gene expressions of voltage-gated (K v ), Ca 
+ channel, tumor marker Clinical diagnosis of prostate cancer (PCa) is usually confirmed by histopathological examination of prostate needle-biopsy among positive cases of blood tests such as PSA (prostate-specific antigen) test. The Gleason score (GS) is the most widely available system for discrimination of malignancy grade in PCa, and patients with GS over 7 have significant risks of death (1, 2) .
In non-excitable cells including cancer cells, membrane hyperpolarization by increase in K + -channel activities causes an increase in intracellular Ca 2+ by providing the driving force for Ca 2+ entry (3, 4) . K + channels are classified into five superfamilies: voltagegated, K v ; Ca 2+ -activated, K Ca ; inward-rectifying, K ir ; ATP-sensitive, K ATP ; two-pore domain, K 2P . During tumor development, a series of genetic alternations affects K + -channel expression and the activation of these channels controls cell proliferation and apoptosis in tumor cells via different signaling pathways (5 -7). Therefore, K + channels have emerged as potential molecular markers and putative therapeutic targets in several types of cancers (8) .
Due to unrestricted accessibility and convenience of experimentation, most studies on K + channels in PCa have been conducted on PCa epithelial cell lines such as LNCaP and PC-3. The data from native human PCa tissues are therefore much sparser and supply valuable information. In the present study, we found a novel malignant grade-dependent expression pattern of three distinct subfamilies of K + -channel genes using needlebiopsy samples of PCa by real-time PCR and may provide a potential tool to quickly detect the malignant grade of PCa.
All tissue specimens were acquired in conformity with the protocols approved by ethics committee at Nagoya City University. Informed consent was obtained from all patients before the study with explanations of the purpose and methods. The age of the patients was 71.5 ± 2.3 years (age range: 66 -82 years, n = 30). Most needle-biopsy samples are obtained from patients in grade GS5-7 to determine whether there was malignancy or not.
Total Statistical significance between two groups or among multiple groups was evaluated using Student's t-test, Welch's t-test, or Tukey's test after the F test or ANOVA. Data were presented as means ± S.E.M. Chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA) and Wako Pure Chemical Industries (Osaka).
A total of 30 prostate biopsies were contributed to real-time PCR analysis: 12 unique samples of benign prostate glands ('nonmalignant') and 18 unique samples of primary PCa. The mean serum PSA was 5.9 ± 0.2 and 12.8 ± 1.6 ng / ml in nonmalignant and PCa samples, respectively (P<0.01).
We first examined the expression levels of three distinct K + channel superfamilies (29 subtypes of K v , 5 subtypes of K Ca , 18 subtypes of K 2P ) in PCa needlebiopsy samples with GS7 using non-quantitative RT-PCR analysis (35 cycles). Six subtypes (K v 1.3, K v 4.3, K Ca 1.1, K Ca 3.1, K 2P 1, and K 2P 3) were abundantly expressed (not shown).
We then examined that the expression levels of K v 1.3, K v 4.3, K Ca 1.1, K Ca 3.1, K 2P 1, and K 2P 3 transcripts using quantitative, real-time PCR analysis (Fig. 1) . In the nonmalignant group, the relative expression levels of K v 1.3, K v 4.3, K Ca 1.1, K Ca 3.1, K 2P 1, and K 2P 3 to β-actin were 0.020 ± 0.003, 0.006 ± 0.001, 0.007 ± 0.001, 0.004 ± 0.001, 0.006 ± 0.002, and 0.030 ± 0.010, respectively (Fig. 1) . On the other hand, in PCa samples with GS5-9, the relative expression levels were 0.054 ± 0.007, 0.010 ± 0.002, 0.010 ± 0.002, 0.015 ± 0.003, 0.040 ± 0.004, and 0.078 ± 0.018, respectively (Fig. 1) . The threshold cycle (Ct) values at 0.25 were 18.2 ± 0.2 and 18.3 ± 0.1 in nonmalignant and PCa groups, respectively, and no significant difference in β-actin expression was detected. These results showed that expressions of K v 1.3, K Ca 3.1, K 2P 1, and K 2p 3 transcripts in the PCa group were significantly increased compared with those in the nonmalignant one.
We further analyzed the grade-dependency of their expressions in the PCa groups with GS 5-6, GS 7, and GS8-9, using the data shown in Fig. 1 . Of interest, expressions of both K Ca 1.1 and K Ca 3.1 in the PCa groups with GS7 and GS8-9 were markedly decreased compared with those in the GS5-6 group. The expression levels of K Ca 1.1 were 0.021 ± 0.004 (n = 6), 0.004 ± 0.001 (n = 8), and 0.003 ± 0.001 (n = 4) in the PCa groups with GS5-6, GS7, and GS8-9, respectively (Fig. 2C) . The expression levels of K Ca 3.1 were 0.030 ± 0.004, 0.009 ± 0.002, and 0.004 ± 0.001, respectively (Fig. 2D) . On the other hand, the expression levels of K v 1.3 and K 2P 1 transcripts showed no significant difference between the PCa groups with GS5-6 and GS7, respectively. However, significant decreases were detected in the GS8-9 group (K v 1.3: 0.063 ± 0.006, 0.071 ± 0.004, and 0.006 ± 0.001, K 2P 1: 0.051 ± 0.007, 0.044 ± 0.004, and 0.017 ± 0.003, respectively) ( Fig. 2: A and E). The changes in Kv4.3 and K 2p 3 were not significant among the three PCa groups, respectively (Fig. 2: B and F) .
We showed here the systematic analyses of malignancy grade-dependent K + channel expression in human PCa and first revealed novel biphasic changes in expression of key K + -channel transcripts (K v 1.3, K Ca 1.1, K Ca 3.1, and K 2P 1); there was a marked increase in the lower GS group (GS5-6) and a significant decrease in the higher GS group (GS8-9). The decreases in K Ca 1.1 and K Ca 3.1 were obvious in middle GS (GS7), whereas those of K V 1.3 and K 2P 1 were observed not in GS7 but in GS8-9. Abdul and Hoosein have reported the 'inverse' correlation between K v 1.3 levels and tumor grade in human PCa by immunohistochemistry (10) . In nonexcitable cells such as T-lymphocytes and cancer cells, hyperpolarization of the membrane potential induced by activation of K + channel increases the driving force for the Ca 2+ entry (5, 7). K v 1.3 channel blockers have been developed as potential drugs for autoimmune diseases (11) . In analogy, selective K v 1.3-channel blockers could be useful for chemotherapy of malignant PCa in a lower grade.
K 2P channels contribute to maintaining the resting membrane potentials and are responsible for both cell apoptosis and tumorigenesis (12) . Similar to the case of K v 1.3, the expression of K 2P 1 transcripts also changed in a biphasic manner with the progression grade. Recent reports have shown that K 2P 1 is expressed in a stagespecific manner in ovarian cancer with lowest expression in advanced tumor stages and is down-regulated with loss of the TAp73 activity when TAp73 is switched to oncogenic ΔNp73, which is positively correlated with the GS in human PCa (13, 14) .
Bloch et al. reported that gene amplification of K Ca 1.1, which is observed in a part of 'late-stage' PCa, is associated with overexpression of K Ca 1.1 transcripts and proteins (15) . We first showed here the significant upregulation of both K Ca 1.1 and K Ca 3.1 transcripts in PCa groups with GS5-6 and marked decrease in both in PCa groups with over GS7. These observations suggest that the detection of 'inverse' correlation of the expression between a set of K Ca 1.1 and K Ca 3.1 and another set of K v 1.3 and K 2P 1 may provide rapid and proper decision of GS7 with significant risks of death. The high expressions of all key K + channels strongly suggest that the sample includes lower stage (GS5-6) PCa. All these findings are surely important in clinical settings because most needle-biopsy samples are obtained from patients in grade GS5-7 to determine whether there is malignancy or not.
Additional but notable information obtained in this study is that the expression profiles of key K + -channel transcripts in androgen-dependent and -independent PCa epithelial cell lines (LNCaP and PC-3) were not completely consistent with the patterns in native PCa samples with GS5-6 and GS7. Although the screening of chemicals for anti-PCa therapy is often carried out by use of these cell lines, the efficacy of modulators targeting these K + channels to prevent cancer cell proliferation may not be adequately assayed by use of these cell lines. It is likely that the expression profiles in these PCa cell lines correspond to that of PCa samples with GS8-9 since the malignancy is highly conserved in these cell lines. An alternative explanation with much lower possibility may be that the needle-biopsy sample included many cell types, among which the high expression of key K + channels occurred in non-epithelial cells. This possibility, however, remains to be determined.
In conclusion, our findings suggest that quantification of specific K + -channel genes by real-time PCR is substantially useful for rapid and simple detection of malignancy grade during PCa progression, providing additional values to the established indicators of Gleason grade. In addition, the present study gives new insight into the roles of K + channels during PCa progression and target molecules that may assist in the discovery of novel drugs for PCa treatment.
